These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1593 related articles for article (PubMed ID: 33978234)

  • 1. Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients.
    Sadeghzadeh-Bazargan A; Rezai M; Najar Nobari N; Mozafarpoor S; Goodarzi A
    J Cutan Pathol; 2021 Oct; 48(10):1266-1276. PubMed ID: 33978234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and Sepsis.
    Koçak Tufan Z; Kayaaslan B; Mer M
    Turk J Med Sci; 2021 Dec; 51(SI-1):3301-3311. PubMed ID: 34590796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis.
    Capoferri G; Daikeler T; Mühleisen B; Trendelenburg M; Müller S
    Clin Dermatol; 2022; 40(4):397-401. PubMed ID: 35248687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang, Indonesia: a case report.
    Widysanto A; Wahyuni TD; Simanjuntak LH; Sunarso S; Siahaan SS; Haryanto H; Pandrya CO; Aritonang RCA; Gunawan C; Angela
    J Thromb Thrombolysis; 2021 Aug; 52(2):635-639. PubMed ID: 33205222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
    Carrascosa JM; Morillas V; Bielsa I; Munera-Campos M
    Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):734-742. PubMed ID: 32882184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin manifestations in patients with coronavirus disease 2019.
    Bassetti M; Massone C; Vena A; Dettori S; Conforti C; Giacobbe DR; Zalaudek I
    Curr Opin Infect Dis; 2022 Apr; 35(2):88-94. PubMed ID: 35067520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?
    Novak N; Peng W; Naegeli MC; Galvan C; Kolm-Djamei I; Brüggen C; Cabanillas B; Schmid-Grendelmeier P; Catala A
    Allergy; 2021 Mar; 76(3):698-713. PubMed ID: 32658359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings.
    Fattori A; Cribier B; Chenard MP; Mitcov M; Mayeur S; Weingertner N
    Hum Pathol; 2021 Jan; 107():39-45. PubMed ID: 33161030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
    Bhaskar S; Sinha A; Banach M; Mittoo S; Weissert R; Kass JS; Rajagopal S; Pai AR; Kutty S
    Front Immunol; 2020; 11():1648. PubMed ID: 32754159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.
    Najar Nobari N; Seirafianpour F; Dodangeh M; Sadeghzadeh-Bazargan A; Behrangi E; Mozafarpoor S; Goodarzi A
    Exp Dermatol; 2021 Sep; 30(9):1233-1253. PubMed ID: 33977531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
    Abdel Moneim A; Radwan MA; Yousef AI
    Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enlightening role for cytokine storm in coronavirus infection.
    Zhao Z; Wei Y; Tao C
    Clin Immunol; 2021 Jan; 222():108615. PubMed ID: 33203513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous, skin histopathological manifestations and relationship to COVID-19 infection patients.
    Li H; Zhao Y; Zhou L; Hu J
    Dermatol Ther; 2020 Nov; 33(6):e14157. PubMed ID: 32770717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.